⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024Brain and BehaviorOpen Access

Sodium‐glucose cotransporter 1/2 inhibition and risk of neurodegenerative disorders: A Mendelian randomization study

Jinxin Liu Xinxiu Shi Yankun Shao

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study aims to evaluate the effects of sodium-glucose cotransporter 1 inhibitors (SGLT1i) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) on neurodegenerative disorders and to investigate the role of hemoglobin A1c (HbA1c) levels.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e61caeb6db6435875af4d0 https://doi.org/10.1002/brb3.3624

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study2024 · 34 citations
2Mendelian randomization study of sodium–glucose cotransporter 2 inhibitors in cardiac and renal diseases2024 · 3 citations
3SGLT2 inhibition, blood lipids, and cardiovascular disease: A Mendelian randomization study2024 · 8 citations
4Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia2024 · 32 citations
5Two Birds With One Stone: The Protective Role of the Antidiabetic Drug Sodium‐Glucose Cotransporter‐2 Inhibitor in Neurodegenerative Diseases2025 · 1 citations

More related papers

Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline2024
Sodium-glucose Co-transporter 2 Inhibitors Lower the Risk for Dementia in Patients with Type 2 Diabetes Mellitus (S28.004)2024
Mendelian Randomization Analyses Indicate a Causal Association Between Sodium-Glucose Cotransporter-1 Inhibition and Mitochondrial Function2026

More from Brain and Behavior

Oral Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Ischemic Stroke or High‐Risk Transient Ischemic Attack: Systematic Review and Meta‐AnalysisThu,
Bridging Thrombolysis Versus Direct Endovascular Thrombectomy in Acute Ischemic Stroke Patients With ASPECTS ≤5: A Meta‐AnalysisThu,